CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 358

Industry reads hand-picked by our editors

Jun 16, 2015

Reuters
Cigarettes linked to half of deaths from 12 common cancers
FierceBiotech
Where Briggs Morrison ended up after leaving AZ
Star Tribune
Big changes coming for U of Minn. researchers with new ethics policy

Jun 15, 2015

Reuters
World's first penis transplant patient to father a child
FiercePharma
FDA, PatientsLikeMe team up for drug safety monitoring
Bloomberg
CVS to pay $1.9B for pharmacies in Target stores

Jun 12, 2015

WSJ
Prisoners sue Mass. for withholding hep C drugs
Reuters
World's first penis transplant patient to father a child
Reuters
WHO approves China flu vax, lauds growing industry

Jun 11, 2015

BuzzFeed
Fear and loathing delay rollout of HIV-blocking drug to those most at risk in Los Angeles
Globes
Teva raises Mylan stake yet again
Reuters
India scraps import duties on AIDS drugs to battle shortage

Jun 10, 2015

Market Watch
Novartis says secukinumab effective for ankylosing spondylitis
Reuters
Roche's Actemra nabs FDA breakthrough designation
Reuters
Could a honey-based mead help curb antibiotic resistance?

Jun 09, 2015

WSJ
Cardiac biomarker lab Health Diagnostic files for chapter 11
FiercePharmaMarketing
Brutal honesty in drug marketing may be key for obesity meds
In-Pharmatechnologist
EMA calls for stakeholder input in design of new trials database

Jun 08, 2015

Reuters
Shire contemplating Actelion buyout
Pharma Times
Mylan launches first generic of Glaxo asthma blockbuster
FiercePharma
NICE reverses course, endorses Bayer prostate cancer med

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
The state of drug pricing in 2024 Supported by GoodRx
Trendline
The latest developments in oncology research Supported by EVERSANA
Webinar - on demand
Biomanufacturing: Scale-up vs Scale-out Economics Custom content for Cytiva

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.